Middle-East and Africa Cancer Vaccines Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Middle-East and Africa Cancer Vaccines Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Middle East and Africa Cancer Vaccine Market are expected to register a CAGR of 9.6% during the forecast period.

Global health care services have been severely impacted by the COVID-19 pandemic. Particularly in low-resource countries, the pandemic has disrupted cancer services. As per the article published in October 2021 titled, 'Impact of the COVID-19 pandemic on cancer diagnosis, treatment, and research in African health systems: a review of current evidence and contextual perspectives,' to make the best use of the limited resources for cancer management in COVID-19 epidemic settings, oncology centers, and institutes across the region have created clinical practice guidelines and recommendations. Additionally, the pandemic has affected African cancer screening and diagnostic programs. Cancer screening programs (including mammograms and pap smears) were discontinued in Morocco due to the early rise in COVID-19 cases. Similar circumstances have been recorded in Uganda, where COVID-19 movement restrictions across the country and social segregation measures have resulted in the cessation of cancer screening programs and outreach initiatives. Therefore, it is observed that COVID-19 has affected the market studied significantly.

Cancer is one of the major causes of morbidity and mortality and is a rising burden on health costs in Saudi Arabia. The most common cancers in Saudi Arabia are breast, colorectal, prostate, brain, lymphoma, kidney, and thyroid. Thus, the demand for cancer vaccines is also rising. According to GLOBOCAN 2020, data updated in February 2021, around 27,885 new cancer cases were reported in Saudi Arabia in 2020. Around 4,807 new cancer cases in the United Arab Emirates (UAE) and 3,842 new cancer cases were reported in Kuwait in 2020. The rising prevalence of cancer will boost the demand for cancer vaccines and further drive market growth.

The incidence of cancer is increasing every year, which has primarily increased the demand for vaccines in research and development for cancers. The cancer is found to damage the immune system, as cancer cells produce self-antigen. Cancer vaccines thus play a vital role in the maintenance of the immune system, as they are considered to be biological response modifiers. These cancer vaccines target the infectious agents that may cause cancer, through the production of antibodies. Cancer vaccines are thus considered to be a new therapy and are not popular, as compared to other alternative therapeutic drugs. However, cancer vaccines have shown great potential in both preventive and therapeutic ways. Moreover, healthcare physicians are looking for alternate therapies, due to the huge burden of cancer cases and the side effects of the present therapies. Hence, the market for cancer vaccines is expected to grow at a high rate, during the forecast period.

Key Market TrendsCervical Cancer Segment is Expected to grow Fastest During the Forecast Period

Cervical cancer is cancer of the cells in the cervix. The rising burden of cervical cancer across Middle East and Africa region is propelling the growth of the segment.

The initiatives taken by public and private organizations in the Middle East and Africa region are fueling the growth of the cancer vaccine market. For instance, in January 2022, a research study was published titled "Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services?" stated that as of 2020, the proportion of adolescent girls aged 15 years who had received at least one dose of the HPV vaccine at any time between ages 9–14 years was 75%, while 61% had completed the full recommended two-dose schedule. Overall, sustained implementation of a nationwide school-based HPV vaccination program in South Africa has been successful, at least over the past 6 years. Hence, such studies provide the advantages of vaccination programs. This will increase the demand for vaccination and thus the market is expected to grow in the future.

Similarly, in June 2020, the American Cancer Society (ACS) and the Clinton Health Access Initiative (CHAI) signed agreements with pharmaceutical companies Pfizer, Novartis, and Mylan to expand access to 20 lifesaving cancer treatments in 26 countries in sub-Saharan Africa and Asia. In January 2022, South African-born United States billionaire Patrick Soon-Shiongand South African President Cyril Ramaphosa reported opening a new vaccine manufacturing plant. It is hoped the facility will soon start making Africa’s first locally produced COVID-19 vaccines, as well as cancer vaccines and other pharmaceuticals. It aims to hasten the domestic production of pharmaceuticals and vaccines that will reach patients across the African continent.

Hence, due to the above-mentioned developments, the cancer vaccines market is expected to witness significant growth during the forecast period.

GCC is Expected to Witness Strong Growth Over the Forecast Period

The Gulf Cooperation Council (GCC) region comprises the United Arab Emirates, Saudi Arabia, Qatar, Oman, Kuwait, and Bahrain. The factors such as the growing burden of cancer disorder, increasing focus on research and development of novel therapeutics, and the growing geriatric population.

Growth in the geriatric population in the region is one of the major factors driving the growth of the market. For instance, according to the United Nations Population Fund’s World Population Dashboard’s Statistics 2021, in Kuwait, approximately 3.4% of the population of the country is aged 65 years and above. Furthermore, according to GLOBOCAN, around 27,885 new cancer cases were reported in Saudi Arabia in 2020. Around 4,807 new cancer cases in the United Arab Emirates (UAE) and 3,842 new cancer cases were reported in Kuwait in 2020. The rising prevalence of cancer will boost the demand for cancer vaccines and further drive market growth. Thus, owing to the abovementioned factors, the studied market is expected to grow over the forecast period in the GCC region.

In January 2020, an awareness campaign was launched about head, neck, and thyroid cancer by Kuwait Cancer Center. Based on statistics issued by Kuwait Cancer Center, thyroid cancer as well as head and neck cancers, which include cancers of the mouth, nose, sinuses, salivary glands, throat and lymph nodes in the neck constitute nearly 10 percent of all cancers in the country. Hence, such a campaign would increase the treatment including cancer vaccines in the country which will fuel the market growth.

Competitive Landscape

The Middle East and Africa Cancer Vaccines Market are moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product developments. Some of the major players are Astellas Pharma Inc., AstraZeneca PLC, Merck & Co. Inc, GlaxoSmithKline, Bristol-Myers Squibb.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.